Bank of America’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,516,505
Closed -$12.4M 8670
2025
Q1
$12.4M Buy
2,516,505
+608
+0% +$1.93K ﹤0.01% 2919
2024
Q4
$7.4M Buy
2,515,897
+1,912,771
+317% +$7.85M ﹤0.01% 3226
2024
Q3
$2.85M Sell
603,126
-3,650
-0.6% -$16.5K ﹤0.01% 4258
2024
Q2
$2.34M Buy
606,776
+76,713
+14% +$346K ﹤0.01% 4329
2024
Q1
$2.84M Buy
530,063
+360,019
+212% +$1.69M ﹤0.01% 4159
2023
Q4
$726K Sell
170,044
-135,630
-44% -$417K ﹤0.01% 5236
2023
Q3
$1.2M Buy
305,674
+155,647
+104% +$1.02M ﹤0.01% 4680
2023
Q2
$1.52M Sell
150,027
-249,909
-62% -$2.65M ﹤0.01% 4451
2023
Q1
$4.08M Buy
399,936
+248,244
+164% +$2.84M ﹤0.01% 3711
2022
Q4
$1.42M Buy
151,692
+28,784
+23% +$406K ﹤0.01% 4561
2022
Q3
$1.79M Buy
122,908
+59,743
+95% +$887K ﹤0.01% 4381
2022
Q2
$833K Sell
63,165
-269,777
-81% -$3.68M ﹤0.01% 5062
2022
Q1
$5.68M Buy
332,942
+183,690
+123% +$3.12M ﹤0.01% 3488
2021
Q4
$3.83M Buy
+149,252
New +$4.66M ﹤0.01% 3923

Other funds holding TSVT

Bank of America's TSVT Position: Q2 2025 in Review

Bank of America sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 2,516,505 shares — an estimated $12.4M sold.

Bank of America first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $12.4M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Bank of America reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 2,516,505 2seventy bio shares in Q2 2025, an estimated $12.4M.
  • Bank of America first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Bank of America's 2seventy bio position peaked at $12.4M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.